A practical 2-page resource to help you get started in any GLP-1 conversation, and provide guidance around tracking side effects and setting realistic nutrition goals
Clinical trials have demonstrated its efficacy in significantly lowering HbA1c levels and promoting weight loss compared to other diabetes medications
Clinical studies Compared with the considerable amount of pre-clinical and mechanistic research reported above, we identified few clinical studies of GLP-1RAs for substance-use disorders (Table 2): three for alcohol 111,112,113 , one for cannabis 114 , two for cocaine 115,116 and two for nicotine 117,118 , while no article about opiates or amphetamines was retrieved
Sep-Oct 2014;29(5):432-42
1:12 Skriver C, Friis S, Knudsen LB, Catarig AM, Clark AJ, Dehlendorff C, Mrch LS (2023) Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort study